2018
DOI: 10.1016/j.jcyt.2018.02.310
|View full text |Cite
|
Sign up to set email alerts
|

Human ascites does not affect NK-92 cytotoxicity and intraperitoneal compared with intravenous administration of NK-92 shows superior survival in human ovarian cancer xenografted mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…xenograft mouse model of human ovarian cancer. 27 Two preliminary studies were designed to determine the appropriate dose and interval for multiple dosing of irradiated NK111-αEpCAM-CAR. First, a single-dose escalation study revealed that 3 × 10 7 cells of NK111-αEpCAM-CAR were required to achieve noticeable tumor regression from day 7 post treatment (Figure S9).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…xenograft mouse model of human ovarian cancer. 27 Two preliminary studies were designed to determine the appropriate dose and interval for multiple dosing of irradiated NK111-αEpCAM-CAR. First, a single-dose escalation study revealed that 3 × 10 7 cells of NK111-αEpCAM-CAR were required to achieve noticeable tumor regression from day 7 post treatment (Figure S9).…”
Section: Resultsmentioning
confidence: 99%
“…Given the importance of multiple genetic modifications to the success of ACT therapies and the challenges associated with the manufacture and testing of multigene-modified products, NK cell line platforms are gaining increasing attentions for their unlimited engineering potential and industrial scalability along with cellular uniformity, long-term stability and batch-to-batch consistency that enable extensive characterization of final products. 27 , 28 In this study, we used a novel human NK cell line, NK101, as a backbone to integrate six transgenes through three rounds of lentiviral transduction, representing the most extensive genetic modifications described so far for any NK cell line. As a result, we have successfully derived clonal, multigene-modified cell therapeutics capable of exerting various modes of antitumor actions: (i) activation receptor-mediated innate killing; (ii) tumor-directed, antigen-specific killing; and (iii) bystander effect-mediated killing.…”
Section: Discussionmentioning
confidence: 99%